Chad Mirkin, PhD

Dr. Mirkin, in collaboration with Dr. Stegh, is working to develop novel and potent nanotechnological agents for the treatment of malignant glioma. "Together with our industry partners, we aim to drive nanotechnology towards pharmaceutical opportunities and to improve the survival of patients with brain tumors," says Dr. Stegh.

Click here for additional information and updates on Dr. Mirkin's research.

Previous Page

Northwestern University | Maps & Directions | Referral/Make an Appointment
© Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Clinical Cancer Center: 866.LURIE.CC || Chicago Administrative Office: 312.908.5250.
Contact us with questions at:
National Comprhensive Cancer Network National Cancer Institute